Genmab — Januar 2018
-
God morgen.
-
god morgen
-
God morgen, itf kombi med PD1/PD-L1 tror jeg først, at vi ser statistiske resultater, der viser en evt forskel - altså ikke historier om enkelte pts forløb. Det må være dybde af respons, OR og ikke mindst længde af respons, der ser ud til at blive forbedret, når Dara for alvor kommer i spil ved opregulering af CD38 - hvor PD1 inhibitors ellers normalt ser ud til at miste virkningen.
-
Go'morgen der falder en bombe i US i dag se link i aktiesnakken, korruption på højeste niveau i administrationen i US, hele det socialistiske, globalistiske korthus vælter i aften med Hillary, Obama og FBI i spidsen. Overvældende beviser og masser af informanter i FBI.
-
-
oh that is a nice find! I was just looking at genmab website yesterday, i think they just updated/ maintained a bit http://www.genmab.com/product-pipeline/products-in-development
-
Kan kun læse overskriften https://medwatch.dk/secure/Medicinal___Biotek/article10243049.ece?utm_source=Feed&utm_medium=latest
-
Det er ikke meget der sker i chatten i dag. Did you drink too many heineken last night E L?
-
GEN patent på HER2 ADC! Hvor passer den ind pre clinical? http://www.freshpatents.com/-dt20180125ptan20180022816.php
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind